XML 39 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET LOSS PER COMMON SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] For the years ended December 31, 2023 and 2022 since the Company had net losses, the effect of common stock equivalents is anti-dilutive, and, as such, common stock equivalents have been excluded from the calculation.
   

Year Ended

December 31, 2023

   

Year Ended

December 31, 2022

 

Basic net loss per share computation:

               

Net loss

  $ (1,070,095 )   $ (282,219 )

Weighted-average common shares outstanding

    5,259,595       5,167,081  

Basic net loss per share

  $ (0.20 )   $ (0.05 )

Diluted net loss per share computation:

               

Net loss per above

  $ (1,070,095 )   $ (282,219 )

Weighted-average common shares outstanding

    5,259,595       5,167,081  

Incremental shares for convertible promissory note,

warrants and stock options

    -       -  

Total adjusted weighted-average shares

    5,259,595       5,167,081  

Diluted net loss per share

  $ (0.20 )   $ (0.05 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share.
   

Year Ended

December 31, 2023

   

Year Ended

December 31, 2022

 

Stock options

    -       158,420  

Warrants

    -       -  
                 

Total potential dilutive securities not included in loss per share

    -       158,420